Kewalramani Reshma
CEO & President · 9 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 4,981 | $485.11 | $2.4M | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 6,554 | $483.75 | $3.2M | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 16,326 | $0.00 | $0.00 | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 13,041 | $487.76 | $6.4M | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 8,297 | $468.41 | $3.9M | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 26,972 | $0.00 | $0.00 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 11,885 | $0.00 | $0.00 | filing |
| 2025-08-06 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Buy | 5,710 | $389.95 | $2.2M | filing |
| 2025-08-06 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Buy | 4,290 | $389.08 | $1.7M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.